Beruflich Dokumente
Kultur Dokumente
A MBLYOPIA M ANAGEMENT:
G LASSES , PATCHES , D ROPS ,
B EYOND
AND
F UNCTIONAL A MBLYOPIA
FUNCTIONAL AMBLYOPIA
Occlusion
Cataracts
Ptosis
Corneal opacity
FUNCTIONAL AMBLYOPIA
FUNCTIONAL AMBLYOPIA
Any angle
Strabismus
Occlusion
Visual acuity
20/180 OU Teller ??
CT @ distance
Ortho
CT @ near
Ortho
MEM
Pupils, EOMs, VF
Grossly normal
Anterior Seg
Posterior Seg
Normal
AMBLYOPIA
Optotype Recognition
Teller Cards
Allen Symbols
Pediatric symbols
Pediatric symbols
Optotype recognition
Optotype recognition
Uniform spacing/crowding
(within one optotype)
Uniform spacing/crowding?
(within one optotype)
Similar optotypes?
Similar optotypes?
Detection test
Lea Chart
Pediatric symbols
Pediatric symbols
Optotype recognition
Optotype recognition
Uniform spacing/crowding
(within one optotype)
Similar optotypes
Similar optotypes
Lea symbols all look the
same at threshold
Optotype recognition
Uniform spacing
crowding maintained by
bars
Similar optotypes
Strabismus: aligned
Refractive error
VA
20/180 OU Teller ??
CT @ distance
Ortho
CT @ near
Ortho
MEM
Pupils, EOMs, VF
Grossly normal
Anterior Seg
Posterior Seg
Normal
Wet Ret
+7.25-1.50X090 OD
+8.00-0.75X090 OS
Visual acuity
Testing Guidelines
Hyperopia +1.50D
Astigmatism 2.00D
Myopia -2.00D
Hyperopia +4.50D
Myopia -3.00D
M EASURING REFRACTIVE
M EASURING REFRACTIVE
ERROR
ERROR
Dry Ret
Autorefraction
Medication
Dosage
Onset of action
Tropicamide
0.5% infants
1.0% >12mos
15-30 mins
4-6 hours
Cyclopentolate
0.5% infants
1.0% >12 mos
15-30 mins
8-24 hours
Atropine
1%
3-6 hours
7-14 days
Suspect resistant
hyperopia
M ADISON
Reduced uncorrected VA
Normal ocular health
VA 20/25- OD and OS
VA 20/40+2 OD; 20/30-1 OS
M ADISON ??
Habitual Rx:
+1.50-3.25X178
+1.00-2.50X169
CT @ dist
Ortho
CT @ near
4-6 XP
2/4 cm
4/12 cm
PFV @ near
X/16/14
NFV @ near
X/35/20
MEM
+0.50 (stable)
Accomm Amps
14D, 12D
NRA/PRA
+2.25/-6.50??
M EASURING R EFRACTIVE
E RROR
M ADISON
1% cyclopentolate
OD
OS
Habitual Rx
+1.50-3.25X178
+1.00-2.50X169
Dry Subjective
+2.00-3.25X178
+1.25-2.50X169
Wet Auto
+3.25-5.00X180
+2.75-4.25X171
Wet Ret
+3.50-4.75X005
+3.75-4.50X171
Final Rx
+2.25-4.75X180
+2.00-4.50X171
RTC 5 weeks:
No headaches since getting glasses!
VA 20/20 OD, OS
R EFRACTIVE E RROR
Bilateral hyperopia 4.50
OD
OS
Wet Ret
+7.25-1.50X090
+8.00-0.75X090
Final Rx
+5.25-1.50X090
+6.00-0.75X090
F OLLOW - UP
Prescribing Guidelines
Rx full cylinder
2.5 years
4 years
R EFRACTIVE ERROR
H ENRY
3.
4.
Anisometropic
5.
+2.00-1.00X180 OU
Hyperopia
6.
+1.00-3.50X180 OU
7.
VA (HOTV)
20/80 OD and OS
CT @ dist
ortho
CT @ near
2-3XP
Wet Ret
+3.75-3.50X013 OD
+3.75-3.25X003 OS
Rx (2D cut)
+1.75-3.50X013
+1.75-3.25X003
1.50D
Astigmatism
2.00D
Myopia
-2.00D
Symmetric
Hyperopia
+4.50D
Astigmatism
2.00D
Myopia
-3.00D
Now what?
H ENRY
Date
HOTV VA
Notes
9/07 (baseline)
3y, 5m
20/80
20/80
2/08
20/32
20/50
Poor compliance
stressed importance
4/08
20/50
20/40
7/08
20/50
20/50
10/08
4y, 6m
6/09
5y, 2m
B RIDGET
Ortho
MEM
Stereo
Dry Ret/Auto
+3.75-3.25X019
+1.25-0.75X033
20/40
20/40
Good compliance
Wet Ret
+4.75-3.50X025
+2.75-1.00X167
20/25
20/25
Rx (2D cut)
+2.75-3.00X025
+0.75-0.75X167
B RIDGET
B RIDGET
ortho
Stereo
500 sec
Hab Rx
+2.75-3.00X025
+0.75-0.75X167
Ortho
Hab Rx
+2.75-3.00X025
+0.75-0.75X167
Stereo
250 sec
M ALACHI
CT @ distance
Ortho
CT @ near
8^ XP
Stereo
Nil
MEM
+0.50
-4.75-1.50X020
M ALACHI FOLLOW UP
2 month follow-up
What next?
Initiate amblyopia tx
A MBLYOPIA T REATMENT
O PTIONS
PATCHING VS ATROPINE
Patching
Patching
1% atropine
Provides stimulation
amblyopic eye
1% Atropine
Advantages
Blocks accomm
Compliance?
Unobtrusive
Mydriasis
Obtrusive
Impaired BV during tx
Disadvantages
Disadvantages
Light sensitivity
Q UESTIONS
restlessness
Irritability
Delirium
Tachychardia
Flushed skin
Ataxia
Convulsions
Fever
Coma
A MBLYOPIA T REATMENT
S TUDIES (ATS)
Parasympatholytic
1% ATROPINE
Advantages
ATS 1
419 kids
Age 3 to <7years
Results
VA improvement
was slightly faster in
the patching group
20/200
20/100
20/50
20/25
Adverse events?
H OW MUCH PATCHING ?
M ORE IS BETTER , RIGHT ?
ATS 2A & B
3 to <7 years
VA 20/100-20/400
3 to <7 years
VA 20/40 to 20/80
2 HOURS VS 6 HOURS
H OW MUCH PATCHING ?
Severe
Amblyopes
20/100 to 20/400
Severe
Amblyopes
6 hours/day
patching
(n=85)
Full time
patching
(n=90)
Moderate
Amblyopes
20/40 to 20/80
Moderate
Amblyopes
2 hours/day
patching
(n=95)
6 hours/day
patching
(n=94)
Baseline
5 Weeks
20/32
Mean Visual Acuity Score
20/400
4 Months
20/32-2 20/32-2
20/40+ 20/40+
20/40
20/50
20/63
20/63+ 20/63+
20/80
2 Hours
N=95
6 Hours
N=94
2 Hours
N=87
6 Hours
N=85
2 Hours
N=92
6 Hours
N=89
PATCHING COMPLIANCE
6-Hour Patching
Group
Poor
Fair
14%
Poor
3%
Fair
58%
25%
11%
15%
Excellent
37%
Excellent
20/50
20/063
20/63-2
20/50-2
20/63-2
20/080
20/100
20/125
20/160+1
20/160
20/160
20/200
37%
Good
20/250
Good
Six-hrs
N=85
ATS2B
Fulltime
N=90
49
PATCHING COMPLIANCE
6-Hour
Patching Group
Full-Time Patching
Group
Poor
Fair
Four-month Exam
20/050
2-Hour
Patching Group
Five-week Exam
20/040
Fair
53% Excellent
10%
32%
15%
Excellent
30%
43%
Good
Good
Severe Amblyopes
If VA stops improving
Fulltime
N=84
ATS2A
Moderate Amblyopes
PATCHING TREATMENT
Sixhrs
N=73
PATCHING TREATMENT
Fulltime
N=77
H OW MUCH PATCHING ?
Poor
5%
11%
Six-hrs
N=75
PATCHING T REATMENT
H OW MUCH ATROPINE ?
168 moderate
amblyopes
ATS 4
168 kids
VA 20/40 to 20/80
weekend atropine
showed 2.3 line
improvement in VA
Parents
reported
slight preference for
daily atropine
2 patients had
ATROPINE COMPLIANCE
Daily Atropine
Group
Poor
Fair
1%
4%
Good
2%
4%
20%
26%
68%
75%
Excellent
Excellent
1% ATROPINE T REATMENT
ADVERSE EFFECTS
Weekend Atropine
Group
Fair Poor
Good
reverse amblyopia
85 weekend
atropine
H OW MUCH ATROPINE ?
83 Daily
Atropine
1% ATROPINE TREATMENT
May consider 1
weekend day and one
weekday
M ALACHI FOLLOW UP
VA not improving
begin treatment
VA improving
monitor q 6 weeks
Amblyopia resolved
routine follow-up (25%)
VA not improving
*Ramp patching up to 6 hours/day
*Ramp atropine to daily
*Consider switching tx or combining
What next?
VA improving continue tx
Initiate amblyopia tx
M ALACHI FOLLOW UP
RTC 3 months
+0.50 OD
-5.75-3.50X034
B RODY
10 CRET
Stereo
Nil
MEM
Hab Rx
+5.75-1.25X167
+2.50-0.75X179
Wet Ret/Final Rx
+6.50-0.75X180
+5.00-0.50X176
Gave full plus
OD cut by 0.75D
OS cut by 2.50D
B RODY
B RODY
8 week follow-up
Patching 2 hours/day
W HY DIDN T B RODY S
AMBLYOPIA RESOLVE ?
B RODY S UMMARY
VA stabilized at 20/40
Treatment equally
effective for all children
under 7 years of age
W HY DIDN T B RODY S
AMBLYOPIA RESOLVE ?
VA not improving
begin treatment
VA improving
monitor q 6 weeks
Amblyopia resolved
routine follow-up (25%)
VA not improving
*Ramp patching up to 6 hours/day
*Ramp atropine to daily
*Consider switching tx or combining
VA improving continue tx
H OW OLD IS TO OLD TO
TREAT AMBLYOPIA ?
H OW LONG TO TREAT ?
507 kids
VA 20/4020/400
Older kids
(13-17yo)
ATS 3
203 received
specs only
201 received tx
2-6 hours
patching
H OW OLD IS TO OLD TO
TREAT AMBLYOPIA ?
Younger
group (7-12)
No previous amblyopia tx
Previous amblyopia tx
H OW OLD IS TO OLD TO
TREAT AMBLYOPIA ?
Upper limit??
ATS 2C
48 received
glasses
55 received tx
21%
3%
Alternative
Definition
Non replicated
2 logMAR VA
No recurrence
Pts
130
14 (40%)
Patching vs Atropine
10 (29%)
21%
25%
120
5 (14%)
110
6 (17%)
75%
79%
100
0
10
15
20
25
30
35
40
45
50
Weeks
21% Recurrence
(95% CI 7% to 35%)
25% Recurrence
(95% CI 17% to 34%)
R ECURRENCE OF AMBLYOPIA
ATS 6
425 kids 3-7 years
20/400
425 kids
2 hours/day
patching with
distance activities
(n=218)
2 hours/day
patching with near
activities (n=207)
Control Group
B ANGERTER O CCLUSION
F OILS
VA improving
monitor q 6 weeks
VA not improving
*Ramp patching up to 6 hours/day
*Ramp atropine to daily
*Consider switching tx or combining
Amblyopia resolved
routine follow-up (25%)
VA improving continue tx
Expect treatment effect within 4-6 months
No need for additional near work
Upper age limit for success unknown
Taper treatment before d/c
89 kids-Bangerter
full time on good
eye
97 kids- 2 hour of
daily patching
B ANGERTER O CCLUSION
F OILS
B ANGERTER O CCLUSION
F OILS
C HANGE IS COMING
Reduction in VA is secondary
T REATING A MBLYOPIA AS A
B INOCULAR CONDITION :
D ICHOPTIC T RAINING
D ICHOPTIC T RAINING IN
A DULTS
D ICHOPTIC T RAINING
18 amblyopic adults
9 played dichoptically
2 lines of improvement in VA
I P OD
T ETRIS
I P OD
Round 1
31 children (412yo)
26 completed
4 wks of tx
Round 2
12 completed
additional 4
weeks of tx
T REATMENT S UMMARY
VA improving
monitor q 6 weeks
VA not improving
*Ramp patching up to 6 hours/day
*Ramp atropine to daily
*Consider switching tx or combining
Amblyopia resolved
routine follow-up (25%)
VA improving continue tx
Expect treatment effect within 4-6 months
No need for additional near work
Upper age limit for success unknown
Taper treatment before d/c